Sawicki P T
Department of Metabolic Diseases and Nutrition, Heinrich-Heine University, Dusseldorf, Germany.
Nephrol Dial Transplant. 1997 Sep;12(9):1890-9. doi: 10.1093/ndt/12.9.1890.
We investigated the effect of achieved continuous tight blood pressure control and intensified insulin therapy on the rate of progression of renal failure in patients with overt diabetic nephropathy and already impaired renal function.
Prospective, randomized, multicentre, follow-up study.
From a screened group of the 66 hypertensive type 1 diabetic patients (IDDM) with overt diabetic nephropathy and reduced glomerular filtration rate who participated in two intensified treatment programmes, 39 patients fulfilled the study inclusion criteria and were enrolled into the 2-year follow-up period. The choice of antihypertensive drugs was based on a randomized allocation to open antihypertensive treatments starting with felodipine, metoprolol, or ramipril.
Progression of renal failure was assessed by measurement of glomerular filtration rate (GFR) on insulin clearance every 6 months.
During the study period mean HbA1c was 8.1 +/- 1.6% and the office blood pressure 143 +/- 14/88 +/- 8 mmHg. The change in GFRinulin (mean and 95% CI) was +1.9 (-2.2; +6.1) ml/min/year. GFR improved in 51%, deteriorated in 39%, and remained stable in 10% of the patients.
This study shows that stabilization of glomerular filtration rate, as assessed by inulin clearance, is possible in patients with overt diabetic nephropathy who reach the goals of intensified antihypertensive treatment even if kidney function is already impaired.
我们研究了实现持续严格血压控制和强化胰岛素治疗对显性糖尿病肾病且肾功能已受损患者肾衰竭进展速度的影响。
前瞻性、随机、多中心随访研究。
从66例参与两项强化治疗方案的显性糖尿病肾病且肾小球滤过率降低的高血压1型糖尿病患者(IDDM)筛查组中,39例患者符合研究纳入标准并进入2年随访期。降压药物的选择基于随机分配至以非洛地平、美托洛尔或雷米普利开始的开放降压治疗。
每6个月通过测量胰岛素清除率的肾小球滤过率(GFR)评估肾衰竭进展。
研究期间平均糖化血红蛋白为8.1±1.6%,诊室血压为143±14/88±8 mmHg。菊粉清除率的GFR变化(均值和95%可信区间)为+1.9(-2.2;+6.1)ml/min/年。51%的患者GFR改善,39%的患者GFR恶化,10%的患者GFR保持稳定。
本研究表明,对于显性糖尿病肾病患者,即使肾功能已受损,若达到强化降压治疗目标,通过菊粉清除率评估,肾小球滤过率有可能实现稳定。